Volume 4 Issue 2, Jun 2019

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)
Volume 4 Issue 2, Jun 2019:
Research Highlight
Normalization cancer immunotherapy: blocking Siglec-15!
Guangchao Cao,Zhiqiang Xiao &Zhinan Yin